---
schema_version: "secwatch.filing_event.v1"
accession: "0001174947-26-000024"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:59:32.909775+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# CONMED provides preliminary 2026 guidance at J.P. Morgan Healthcare Conference; no figures in filing

## Summary
- Presented at J.P. Morgan 44th Annual Healthcare Conference on January 12, 2026.
- Preliminary 2026 financial guidance was included in the investor presentation.
- No specific revenue, EPS, or other guidance figures were disclosed in the filing text.
- Presentation available on CONMED's website under Investors > Presentations.
- CFO Todd W. Garner and CEO Pat J. Beyer presented.

## SEC filing metadata
- accession: 0001174947-26-000024
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000117494726000024/0001174947-26-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000117494726000024/form8k-35073_cnmd.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001174947-26-000024
- JSON: https://secwatch.observer/filing/0001174947-26-000024.json
- Plain text: https://secwatch.observer/filing/0001174947-26-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.